You are here:

salmeterol 25 mcg inhaler (Serevent Evohaler)

Advice

Following an abbreviated submission.

Salmeterol 25 micrograms inhaler (Serevent Evohaler) is accepted for use in NHS Scotland for the regular symptomatic treatment of reversible airways obstruction in patients with asthma, including those with nocturnal asthma or chronic obstructive pulmonary disease. It may also be used for the prevention of exercise-induced asthma.

Where the use of this long-acting beta agonist by aerosol inhalation is appropriate, it offers a chlorofluorocarbon (CFC)-free option at no additional cost

Drug Details

Drug Name: salmeterol 25 mcg inhaler (Serevent Evohaler)
SMC Drug ID: 292/06
Manufacturer: GlaxoSmithKline UK Ltd
Indication: Reversible airways obstruction in patients with asthma
BNF Category:
Sub Category: 3.1 Bronchodilators
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 7 August 2006

Back